Clinical and Laboratory Parameters of Mast Cell Activation as Basis for the Formulation of Diagnostic Criteria
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Mast cell (MC) activation occurs in a number of different pathologic conditions. Acute activation is commonly seen in patients with allergic reactions, with consecutive massive release of vasoactive and proinflammatory mediator substances from MCs, leading to the clinical signs and symptoms of anaphylaxis. In these patients, serum tryptase concentrations usually increase subtantially above baseline levels. Chronic MC activation is more difficult to diagnose, especially when symptoms are mild or atypical, and no underlying disease is found. In these patients, serum tryptase levels usually are normal. In a smaller group of patients, tryptase levels are constantly elevated and may point to an occult form of mastocytosis. These patients have to be examined for MC monoclonality, other criteria of a primary MC disease, non-MC hematopoietic neoplasms, and reactive disorders producing chronic MC activation or MC accumulation. In most patients in whom MC activation is found, histamine-induced symptoms can be documented and usually respond to treatment with histamine receptor antagonists or MC stabilizers. If this is not the case, alternative explanations for symptoms and differential diagnoses have to be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.591 · Cited by 2,391
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108 · cited 1×
“This antigen (low-affinity IL-2 receptor) is not expressed on normal (resting) MCs, but is usually expressed on neoplastic MCs in SM. Therefore, CD25 expression in MCs has been proposed as a minor diagnostic criterion of SM [”
BackgroundSelf-citationHistamine and histamine intolerance
Maintz, L., & Novak, N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1185 · Cited by 864
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationIdentification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals
Valenta, R., Duchêne, M., Pettenburger, K., Sillaber, C., Valent, P., Bettelheim, P., Breitenbach, M., Rumpold, H., Kraft, D., & Scheiner, O. (1991) · Science · doi:10.1126/science.1857985 · Cited by 637 · cited 1×
“In several instances, autoallergens are detected, which points to a relationship to autoimmune disorders [”
BackgroundSelf-citationDiagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477
Bonadonna, P., Perbellini, O., Passalacqua, G., Caruso, B., Colarossi, S., Dal Fior, D., Castellani, L., Bonetto, C., Frattini, F., Dama, A., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.018 · Cited by 392
Schwartz, L. B., Sakai, K., Bradford, T. R., Ren, S., Zweiman, B., Worobec, A. S., & Metcalfe, D. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118337 · Cited by 371 · cited 1×
“A reliable marker in suspected (occult) SM is the basal serum tryptase level. Notably, in most patients with SM, basal tryptase levels are elevated to greater than 20 ng/ml even if skin lesions are not detectable [”
BackgroundAn update on the genetics of atopic dermatitis: Scratching the surface in 2009
Barnes, K. C. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.008 · Cited by 309
Anaphylaxis: a review of 601 cases
Webb, L. M., & Lieberman, P. (2006) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61367-1 · Cited by 286
Mediators of immediate hypersensitivity reactions
Serafin, W. E., & Austen, K. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170106 · Cited by 256
Escribano, L., Orfao, A., Dı́az-Agustin, B., Villarrubia, J., Cerveró, C., López, A., Marcos, M. A. G., Bellas, C., Fernández-Cañadas, S., Cuevas, M., et al. (1998) · Blood · doi:10.1182/blood.v91.8.2731.2731_2731_2736 · Cited by 248
González de Olano, D., De La Hoz Caballer, B., Núñez López, R., Sánchez Muñoz, L., Cuevas Agustín, M., Diéguez, M. C., Álvarez Twose, I., Castells, M. C., & Escribano Mora, L. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02804.x · Cited by 245
Akin, C., Scott, L. M., Kocabas, C. N., Kushnir-Sukhov, N., Brittain, E., Noel, P., & Metcalfe, D. D. (2007) · Blood · doi:10.1182/blood-2006-06-028100 · Cited by 240
Diagnostic Value of Immunostaining for Tryptase in Patients With Mastocytosis
Horny, H.-P., Sillaber, C., Menke, D., Kaiserling, E., Wehrmann, M., Stehberger, B., Chott, A., Lechner, K., Lennert, K., & Valent, P. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199809000-00013 · Cited by 231
Self-citationBühring, H.-J., Streble, A., & Valent, P. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000077351 · Cited by 231
Self-citationHorny, H.-P., & Valent, P. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00021-2 · Cited by 227
Self-citationMast cells: function and contents
Schwartz, L. B. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90039-6 · Cited by 211
Understanding the mechanisms of anaphylaxis
Peavy, R. D., & Metcalfe, D. D. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3283036a90 · Cited by 211
Sperr, W. R., Jordan, J.-H., Fiegl, M., Escribano, L., Bellas, C., Dirnhofer, S., Semper, H., Simonitsch-Klupp, I., Horny, H.-P., & Valent, P. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000059404 · Cited by 207
Self-citationRuëff, F., Przybilla, B., Biló, M. B., Müller, U., Scheipl, F., Aberer, W., Birnbaum, J., Bodzenta-Lukaszyk, A., Bonifazi, F., Bucher, C., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.025 · Cited by 202
Diagnostic Tests Based on Human Basophils: More Potentials and Perspectives than Pitfalls
de Weck, A. L., Sanz, M. L., Gamboa, P. M., Aberer, W., Bienvenu, J., Blanca, M., Demoly, P., Ebo, D. G., Mayorga, L., Monneret, G., et al. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000115885 · Cited by 184
Chapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE
Rivera, J., Fierro, N. A., Olivera, A., & Suzuki, R. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00403-3 · Cited by 180
Immunoanalysis of histamine through a novel chemical derivatization
Morel, A. M., & Delaage, M. A. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90978-5 · Cited by 180
Markers of Mast Cell Degranulation
Hogan, A. D., & Schwartz, L. B. (1997) · Methods · doi:10.1006/meth.1997.0494 · Cited by 178
Sotlar, K., Horny, H.-P., Simonitsch, I., Krokowski, M., Aichberger, K. J., Mayerhofer, M., Printz, D., Fritsch, G., & Valent, P. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000138181.89743.7b · Cited by 174
Self-citationAdvances in mechanisms of asthma, allergy, and immunology in 2010
Broide, D. H., Finkelman, F., Bochner, B. S., & Rothenberg, M. E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.027 · Cited by 173
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals
Hauswirth, A. W., Natter, S., Ghannadan, M., Majlesi, Y., Schernthaner, G.-H., Sperr, W. R., Bühring, H.-J., Valenta, R., & Valent, P. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.125257 · Cited by 169
Self-citationHorny, H.-P., Sotlar, K., Sperr, W. R., & Valent, P. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014860 · Cited by 163
Self-citationHENNERSDORF, F., FLORIAN, S., JAKOB, A., BAUMGÄRTNER, K., SONNECK, K., NORDHEIM, A., BIEDERMANN, T., VALENT, P., & BÜHRING, H.-J. (2005) · Cell Research · doi:10.1038/sj.cr.7290301 · Cited by 158
Self-citationFrom allergen structure to new forms of allergen-specific immunotherapy
Valenta, R., & Kraft, D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00402-8 · Cited by 147
Valenta, R., Natter, S., Seiberler, S., Wichlas, S., Maurer, D., Hess, M. W., Pavelka, M., Grote, M., Ferreira, F., Szépfalusi, Z., et al. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00413.x · Cited by 137
Self-citationSonneck, K., Florian, S., Müllauer, L., Wimazal, F., Födinger, M., Sperr, W. R., & Valent, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096442 · Cited by 129
Self-citationLieberman, P. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3283036a69 · Cited by 109
Sanz, M. L., Sánchez, G., Gamboa, P. M., Vila, L., Uasuf, C., Chazot, M., Diéguez, I., & De Weck, A. L. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01122.x · Cited by 103
Systemic Anaphylaxis in the Human Being
Austen, K. F. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409262911306 · Cited by 100 · cited 1×
“Clinical symptoms originating from mast cell (MC) activation with release of granular mediators may be one of the most frequently recorded features in general medicine. Symptoms range from mild headache or fatigue to ulcerative gastrointestinal disease, from itching to life-threatening hypotension and anaphylaxis, and…”
BackgroundAutoimmunity and atopic dermatitis
Mittermann, I., Aichberger, K. J., Bünder, R., Mothes, N., Renz, H., & Valenta, R. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200410000-00007 · Cited by 90
SERUM TRYPTASE AND THE LABORATORY DIAGNOSIS OF SYSTEMIC MASTOCYTOSIS
Schwartz, L. B., & Irani, A.-M. A. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70300-2 · Cited by 87
Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Escribano, L., Akin, C., Castells, M., & Schwartz, L. (2006) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152806775269303 · Cited by 86
Florian, S., Krauth, M.-T., Simonitsch-Klupp, I., Sperr, W. R., Fritsche-Polanz, R., Sonneck, K., Födinger, M., Agis, H., Böhm, A., Wimazal, F., et al. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000083954 · Cited by 79
Self-citationSainte‐Laudy, J., Sabbah, A., Vallon, C., & Guérin, J. C. (1998) · Inflammation Research · doi:10.1007/s000110050351 · Cited by 74 · cited 1×
“If no signs of MC monoclonality or other underlying disorders are found, the condition is termed ‘idiopathic MCAS’ (table 3 ). All in all, monoclonal and idiopathic MCAS can be well differentiated from allergic diseases and primary MC disorders (table 3 ). 2 Table 2. Conditions/disorders that can present with elevated…”
BackgroundGrützkau, A., Тихоновна, С. А., Lippert, U., Kirchhof, L., Artuc, M., & Henz, B. M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20068 · Cited by 70
Platz, I. J., Binder, M., Marxer, A., Lischka, G., Valent, P., & Bühring, H.-J. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049531 · Cited by 67
Self-citationSerum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease
Sirvent, A. E., González, C., Enríquez, R., Fernández, J., Millán, I., Barber, X., & Amorós, F. (2010) · Journal of Nephrology · doi:10.1093/joneph/23.3.282 · Cited by 66
Golden, D. B. K. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3281f8290c · Cited by 61
Anaphylaxis and Mast Cell Disease: What Is the Risk?
Akin, C. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-009-0080-8 · Cited by 59
Differential Diagnosis of the Patient with Unexplained Flushing/Anaphylaxis
Metcalfe, D. D. (2000) · Allergy and Asthma Proceedings · doi:10.2500/108854100778249006 · Cited by 53 · cited 1×
“Other causative disorders such as systemic mastocytosis (SM) are less frequent [”
BackgroundAssessing anaphylactic risk? Consider mast cell clonality
Metcalfe, D. D., & Schwartz, L. B. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.003 · Cited by 52
Surrogate Markers of Disease in Mastocytosis
Akin, C., & Metcalfe, D. D. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000048184 · Cited by 49
Hauswirth, A. W., Escribano, L., Prados, A., Nuñez, R., Mirkina, I., Kneidinger, M., Florian, S., Sonneck, K., Vales, A., Schernthaner, G.-H., et al. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100404 · Cited by 48
Self-citationHistamine intolerance: a metabolic disease?
Schwelberger, H. G. (2009) · Inflammation Research · doi:10.1007/s00011-009-0134-3 · Cited by 48
Greenhawt, M., & Akin, C. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3282a6443e · Cited by 47
Assays for measuring in vitro basophil activation induced by recombinant allergens
Valent, P., Hauswirth, A. W., Natter, S., Sperr, W. R., Bühring, H.-J., & Valenta, R. (2004) · Methods · doi:10.1016/j.ymeth.2003.08.006 · Cited by 46
Self-citationDi Lorenzo, G., Pacor, M. L., Vignola, A. M., Profita, M., Esposito‐Pellitteri, M., Biasi, D., Corrocher, R., & Caruso, C. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.23767.x · Cited by 40
The problem of anaphylaxis and mastocytosis
Müller, U. R., & Haeberli, G. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-009-0010-9 · Cited by 37
Ring, J., & Darsow, U. G. (2002) · Current Allergy and Asthma Reports · doi:10.1007/s11882-002-0036-8 · Cited by 35
Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis
van Toorenenbergen, A. W., & Oranje, A. P. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.041 · Cited by 27
Stinging Hymenoptera and mastocytosis
Ruëff, F., Dugas‐Breit, S., & Przybilla, B. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32832d2bc7 · Cited by 26
Sonneck, K., Baumgärtner, C., Rebuzzi, L., Marth, K., Chen, K., Hauswirth, A. W., Florian, S., Vrtala, S., Bühring, H., Valenta, R., et al. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100103 · Cited by 25
Self-citationMast Cells and Mast Cell-Derived Factors in the Regulation of Allergic Sensitization
Taube, C., & Stassen, M. (2008) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000154857 · Cited by 16
Two patients with osteoporosis: initial presentation of systemic mastocytosis
Donker, M. L., Bakker, N. A., Jaspers, W. J. M., & Verhage, A. H. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0800-x · Cited by 9
Research works printed but not linked: 2
- 10.1016%2Fj.jaci.2009.12.981 · DOI · Paper page
- 10.1016%2Fj.jaci.2009.12.936 · DOI
Cited by
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile
Calderón, M. A., Simons, F. E. R., Malling, H. ‐., Lockey, R. F., Moingeon, P., & Demoly, P. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02761.x · Cited by 286
“However, the relationship between serum tryptase levels and chronic mast cell activation is subject to debate (42).”
BackgroundProposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“When MC involvement is documented and the reaction is severe, an MCA syndrome (MCAS) may be diagnosed.(21-28) In the past 50 years, clinical symptoms resulting from MCA have primarily been documented in the context of allergic diseases.”
BackgroundSelf-citationHuman mast cell tryptase in biology and medicine
Vitte, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.04.001 · Cited by 152
The mastocytosis society survey on mast cell disorders: patient experiences and perceptions
Jennings, S., Russell, N., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2013.09.004 · Cited by 143
“Nearly all respondents noted at least one MCD symptom trigger, and many provoking factors were similar to reports found in the literature.(3,4,6,9,16,21,22) Anaphylaxis rates for specific MCD patient populations may be influenced by sex, age, MCD classification, and the presence of skin lesions(8,10,11,16,18,23) and h…”
ResultSelf-citationPredictors of clinical effectiveness of Hymenoptera venom immunotherapy
Ruëff, F., Vos, B., Oude Elberink, J., Bender, A., Chatelain, R., Dugas‐Breit, S., Horny, H. ‐., Küchenhoff, H., Linhardt, A., Mastnik, S., et al. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12275 · Cited by 139
Self-citation
Metadata
- Authors
- Valent, P., Horny, H.-P., Triggiani, M., & Arock, M.
- Affiliations
- Medical University of Vienna (AT)
- University of Naples Federico II (IT)
- Centre National de la Recherche Scientifique (FR)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 156
- Issue
- 2
- Pages
- 119-127
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2091258962
- Cited by
- 50
- References
- 64
- Citations by year
- 2024: 1 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2015: 5 · 2014: 11 · 2013: 7 · 2012: 3
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- mast cell activation, serum tryptase, anaphylaxis, mastocytosis, antihistamines, mast cell stabilizers, diagnostic criteria, differential diagnosis, monoclonality
- MeSH terms
- Bronchial Provocation Tests, Histamine, Humans, Hypersensitivity, Mast Cells, Mastocytosis, Skin Tests, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.